{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:06:38Z","timestamp":1765667198090},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:p>Children with Lyme meningitis are often treated with intravenous ceftriaxone, although oral doxycycline may be effective. Parents were surveyed after observing a video describing a hypothetical Lyme meningitis treatment trial. Eighty-four of 102 (82%) would consent to their child participating. Parents would accept 2 additional days of symptoms (noninferiority margin) with doxycycline even if ceftriaxone hastened symptom resolution.<\/jats:p>","DOI":"10.1097\/inf.0000000000001793","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T22:58:33Z","timestamp":1507071513000},"page":"e140-e142","source":"Crossref","is-referenced-by-count":2,"title":["Would Parents Consent to a Comparative Effectiveness Trial of Oral Doxycycline Versus Intravenous Ceftriaxone for the Treatment of Children with Lyme Meningitis?"],"prefix":"10.1097","volume":"37","author":[{"given":"Aris","family":"Garro","sequence":"first","affiliation":[{"name":"Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Koster","sequence":"additional","affiliation":[{"name":"Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"LaRue","sequence":"additional","affiliation":[{"name":"Lifespan Corporation, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Hipolito","sequence":"additional","affiliation":[{"name":"Lifespan Corporation, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Congdon","sequence":"additional","affiliation":[{"name":"Lifespan Corporation, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Burnett","sequence":"additional","affiliation":[{"name":"Providence College, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Cullen","sequence":"additional","affiliation":[{"name":"Providence College, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise E.","family":"Nigrovic","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.1993.tb18082.x","article-title":"Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis.","volume":"386","author":"Christen","year":"1993","journal-title":"Acta Paediatr Suppl"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/INF.0b013e31825eb3c7","article-title":"Treatment complications in children with lyme meningitis.","volume":"31","author":"Thompson","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/ene.12744","article-title":"Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis\u2014a systematic review.","volume":"22","author":"Dersch","year":"2015","journal-title":"Eur J Neurol"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","article-title":"Practice Parameter : Treatment of nervous system Lyme disease (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"69","author":"Halperin","year":"2007","journal-title":"Neurology"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1128\/AAC.40.5.1104","article-title":"Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis.","volume":"40","author":"Karlsson","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00365540510027228","article-title":"Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis.","volume":"37","author":"Borg","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","article-title":"Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.","volume":"7","author":"Lj\u00f8stad","year":"2008","journal-title":"Lancet Neurol"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.44.7.1203","article-title":"Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis.","volume":"44","author":"Karlsson","year":"1994","journal-title":"Neurology"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201805000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:36:14Z","timestamp":1694558174000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201805000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001793","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}